Hoth Therapeutics Inc
(HOTH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 2,193 | 3,421 | 2,684 | 2,300 | 2,661 |
| Operating Income | -2,193 | -3,421 | -2,684 | -2,300 | -2,661 |
| Other Income | 9 | -58 | 40 | -378 | 89 |
| Pre-tax Income | -2,184 | -3,479 | -2,644 | -2,678 | -2,572 |
| Net Income Continuous | -2,184 | -3,479 | -2,644 | -2,678 | -2,572 |
| Net Income | $-2,184 | $-3,479 | $-2,644 | $-2,678 | $-2,572 |
| EPS Basic Total Ops | -0.88 | -2.61 | -2.05 | -2.16 | -2.68 |
| EPS Basic Continuous Ops | -0.88 | -2.60 | -2.05 | -2.16 | -2.68 |
| EPS Diluted Total Ops | -0.88 | -2.61 | -2.05 | -2.16 | -2.68 |
| EPS Diluted Continuous Ops | -0.88 | -2.60 | -2.05 | -2.16 | -2.68 |
| EBITDA(a) | $-2,193 | $-3,421 | $-2,684 | $-2,300 | $-2,661 |